NCT02248519Completed
Laparoscopic Versus Open Gastrectomy for Gastric Cancer
Laparoscopic Versus Open Gastrectomy for Gastric Cancer, a Multicenter Prospectively Randomized Controlled Trial (LOGICA-trial)
Source: ClinicalTrials.gov · Last updated 19 Feb 2026
Brief summary (registry, in English)
This is the first randomized controlled trial comparing laparoscopic and open gastrectomy for resectable gastric cancer in a Western population. The hypothesis is that laparoscopic gastrectomy will result in a lower post-operative burden by means of shorter post-operative hospital stay. Secondarily that laparoscopic gastrectomy is hypothesized to be associated with lower post-operative morbidity and readmissions, higher cost-effectiveness, and better post-operative quality of life, with similar mortality and oncologic outcomes, compared to open gastrectomy. The study starts on 1 December 2014. Inclusion and follow-up will take three and five years respectively. Short-term results will be analyzed and published after discharge of the last randomized patient.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 210 (actual)
- First submitted
- 17 Sept 2014
- Start date
- 1 Dec 2014
- Primary completion date
- 1 Nov 2018
- Lead sponsor
- UMC Utrecht
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT02248519
What you commit to
- Study type: Interventional
- Participants enrolled: 210
- From 1 Dec 2014 to the primary completion date, 1 Nov 2018
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Non-elective surgery
- Previous gastric resection or recurrent gastric cancer
Other
- Siewert type I esophagogastric junction tumor
- Pregnancy
Who the study is looking for
- Histologically proven adenocarcinoma of the stomach
- Surgically resectable (cT1-4a, N0-3b, M0) tumor
- Age ≥ 18 years
- European Clinical Oncology Group (ECOG) performance status 0, 1 or 2.
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zorggroep Twente Almelo Coordinator of this site? Confirm its status | Almelo | Netherlands | Unknown status |
| Meander Medical Center Coordinator of this site? Confirm its status | Amersfoort | Netherlands | Unknown status |
| Academic Medical Center Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Unknown status |
| VU University Medical Center Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Unknown status |
| Gelre Hospital Coordinator of this site? Confirm its status | Apeldoorn | Netherlands | Unknown status |
| Catharina hospital Coordinator of this site? Confirm its status | Eindhoven | Netherlands | Unknown status |
| Leiden University Medical Center Coordinator of this site? Confirm its status | Leiden | Netherlands | Unknown status |
| Erasmus Medical Center Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Unknown status |
| Zuyderland Medical Center Coordinator of this site? Confirm its status | Sittard-Geleen | Netherlands | Unknown status |
| University Medical Center Utrecht Coordinator of this site? Confirm its status | Utrecht | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.